OUR LOCATION

322-Washington,America - 23

(+1)123 456 789

Emergency Call- 24/7 support

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Healthcare IT » HHE-3120916
  • Global Digital Therapeutic Market-Technologies, Market share and Industry Forecast to 2024

  • Publish: September 2016 | Report Code: HHE-3120916

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Digital therapeutics is a new discipline of medicine which makes the world’s most effective behavior therapies accessible to patients, by utilizing digital and health technologies to treat a psychological or a physical condition. Treatment by digital therapies depend on the lifestyle and behavioral changes driven by a collection of digital impulses. The global digital therapeutics market is anticipated to grow with a CAGR of 28.1% during the forecast period 2016-2023.The key trend affecting the global digital therapeutics market is the widespread of digital tools in healthcare industry which is contributing to the growth of global digital therapeutics market. The global digital therapeutics market is primarily driven by following factors:

  • Rising prevalence of preventable chronic diseases
  • Increasing attention towards precautionary healthcare
  • Increasing technological advancements
  • Major rise in venture capital investments
  • Huge benefits offered by digital therapeutics






The key factor contributing to the growth of global digital therapeutics market is the rising prevalence of preventable chronic diseases and increasing attention towards precautionary healthcare. The global rise in life style oriented diseases has led the government and private firms to increase the investments made for research and development and for the technological innovations in global digital therapeutics market. The rise in cardiovascular diseases as one of the major chronic diseases is leading to the rise in the usage of digital therapies. Cardiovascular diseases (CVD) are the leading cause of death in China due to urbanization, economic development and change in lifestyle giving rise to stress and eventually leading to the changes in dietary habits and increase in consumption of cigarettes. The lack of access and awareness of digital therapies across developing countries, concerns related to privacy and security of patients’ data and resistance from traditional healthcare providers may hinder the growth of the global digital therapeutics market. The concerns related to privacy and security of patients’ data is one of the major factors restraining the growth of global digital therapeutics market. Factors like huge growth prospects of digital therapies in developing markets, increasing pool of geriatric patients all over world and increasing number of unexplored therapeutic applications pose large growth opportunities for the global digital therapeutics market.

Source: OBRC Analysis

The global digital therapeutics market is segmented into application and sales channel. Application is further segmented into:

  • Preventive applications and treatment
  • Treatment/care related application



Sales channel is further segmented into:

  • Business to business market
  • Business to consumer market



The revenue for the above industrial application is specific to the global digital therapeutics market. However, the total revenue of these applications in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up application and sales channel segments.

Geographically, the global digital therapeutics market is segmented into:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America dominates the global digital therapeutics market, due to the increasing number of geriatric patients and increasing prevalence of chronic diseases. The contribution of some of the key players of North American digital therapeutics market enhances the global digital therapeutics market. Various research and development activities and increasing investing for the development in digital therapeutics technology is expected to enhance the growth of North American digital therapeutics s market in the forecast period 2016-2023. Asia Pacific market is expected to rise with an impressive CAGR in the forecast period due to increasing number of geriatric patients in countries such as India and China. The increasing patient pool in APAC is due to the rise in medical tourism which is contributing to the growth of Asia Pacific digital therapeutics s market.

Global digital therapeutics market is segmented on the basis of application, sales channel. The application segment is further segmented into preventive applications and treatment /care related application. The preventive application is sub segmented into obesity and Prediabetes. The treatment / care related application is also sub segmented into Cardiovascular Diseases, Central Nervous System (CNS) Disorders, Chronic Respiratory Diseases (CRD), Diabetes, Medication Adherence, Musculoskeletal Disorders, Smoking Cessation and Other Applications. The preventive application is expected to grow with the highest CAGR during the forecasted period 2016-2023. The growth in the preventive application segment is due to growing prevalence of preventive chronic diseases across the globe and increasing change in life style and behavioral orientation toward the new surgical procedure. The sales channel segment is further segmented into business-to-business and business-to-consumer segments. The business-to-business segment is sub segmented into employers, payers, pharmaceutical companies, providers and other buyers. The business-to-consumer segment is sub segmented into care-givers and patients. The business-to-business segment is estimated to hold the largest share in the sales channel segment, owing to rapid adoption of the digital therapeutics by various business units. The employers and payers are the major adopters of digital therapeutics as it helps to minimize the cost of healthcare services. 

The major market players of the global digital therapeutics market are:

  • ADHERETECH
  • CANARY HEALTH INC.
  • DOXIMITY
  • EVOLENT HEALTH
  • GE HEALTHCARE
  • OTHERS







Detailed analysis of these companies provided in this report comprises of overview, scot analysis, product portfolio, strategic initiative and strategic analysis.

These companies use various strategies such as mergers & acquisitions, collaboration, partnership and product launching. Example: In 2015 the Medtronic acquired Covidien plc. an Irish-headquartered global health care products company and manufacturer and supplier of medical devices. These acquisition assisted Medtronic to develop the geographical presence and the efficacy of the medical devices. The main motive of acquisition was to expand the working area with more classified product range which enabled the company to sustain in the competitive market.

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such as acquisition, as in 2015, Medtronic acquired the Covidien plc. an Irish global healthcare company.
  • Provide in detail the different segments such as application and sales channel which affect the global digital therapeutics market.
  • Provide you the patent analysis of global digital therapeutics market.
  • Identify and understand the strengths, opportunities, challenges and threat of global digital therapeutics market.
  • Provide revenues of major players of global digital therapeutics market such as GE Healthcare, Medtronic and Adheretech.
  • Provide you the various regulatory policies which affect the global digital therapeutics market.







How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global digital therapeutics market offers the longest chain of market segmentation covering major market segmentation based on application and sales channel.The report tracks the major market trends in the global digital therapeutics market such as widespread of digital tools technology innovation in health industry and so on. For each market segments covered in global digital therapeutics market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the digital therapeutics industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings of the global digital therapeutics market:

  • North America had the largest revenue share in 2016.
  • Preventive application segment is dominating the market due to growing prevalence of preventive chronic diseases across the globe and increasing change in life style and behavioral orientation toward the new surgical procedure.
  • Acquisition is the key strategy adopted by the various market players of global digital therapeutics market.
  • The business-to-business segment is anticipated to hold the largest share in the sales channel segment due to rapid adoption of the digital therapeutics by various business units.

1.       INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2.       MARKET OVERVIEW

2.1. GLOBAL DIGITAL THERAPEUTIC MARKET : EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. TOTAL MARKET ANALYSIS

2.4.1.        TOP 5 FINDINGS

2.4.2.        TOP 5 OPPORTUNITY MARKETS

2.4.3.        TOP 5 COMPANIES

2.4.4.        TOP 3 COMPETITIVE STRATEGIES

2.5. ESTIMATION ANALYSIS

2.6. STRATEGIC ANALYSIS

2.6.1.        INVESTMENT VS. ADOPTION MODEL

2.6.2.        360-DEGREE INDUSTRY ANALYSIS

2.6.3.        PORTERS 5 FORCE MODEL

2.6.4.        SEE-SAW ANALYSIS

2.6.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.7. COMPETITIVE ANALYSIS

2.7.1.        KEY STRATEGIES & ANALYSIS

2.7.2.        MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS

2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.8.1.        INVESTMENT OPPORTUNITIES BY REGIONS

2.8.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

2.8.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3.       MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1.1.  RISING PREVALENCE OF PREVENTABLE CHRONIC DISEASES

3.1.1.2.  INCREASING ATTENTION TOWARDS PRECAUTIONARY HEALTHCARE

3.1.1.3.  RISING TECHNOLOGICAL ADVANCEMENTS

3.1.1.4.  MAJOR RISE IN VENTURE CAPITAL INVESTMENTS

3.1.1.5.  HUGE BENEFITS OFFERED BY DIGITAL THERAPEUTICS

3.2. MARKET RESTRAINTS

3.2.1.        LACK OF ACCESS AND AWARENESS ACROSS EMERGING COUNTRIES

3.2.2.        CONCERN RELATED TO PRIVACY AND SECURITY OF PATIENTS DATA

3.2.3.        RESISTANCE FROM TRADITIONAL HEALTHCARE PROVIDE   RS

3.3. MARKET OPPORTUNITIES

3.3.1.        HUGE GROWTH PROSPECTS IN EMERGING MARKET

3.3.2.        INCREASING ELDERLY POPULATION ACROSS THE GLOBE

3.3.3.        INCREASING NUMBER OF PATIENT POOL IN THE WORLD

3.3.4.         INCREASING NUMBER OF UNEXPLORED THERAPEUTI APPLICATIONS 

3.4. MARKET CHALLENGES

3.4.1.        STRINGENT GOVERNMENT REGULATION AND REGULATORY GUIDELINES

3.4.2.       UNWILLINGNESS AMONG PATIENTS TO ESPOUSE DIGITAL THERAPEUTICS

4.      GLOBAL DIGITAL THERAPEUTIC MARKET BY APPLICATION

4.1. MARKET DEFINITION AND SCOPE

4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.  OPPORTUNITY MATRIX

4.5. MARKET SEGMENTATION

4.5.1.      GLOBAL PREVENTIVE APPLICATIONS APPLICATION  MARKET

4.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3.  MARKET PARTICIPANTS AND PRODUCTS

4.5.1.4.  KEY CONCLUSIONS

4.5.1.5.  SUBSEGMENT

4.5.1.5.1.        OBESITY

4.5.1.5.2.        PREDIABETES

4.5.2.      GLOBAL TREATMENT/CARE-RELATED APPLICATIONS APPLICATION MARKET

4.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3.  MARKET PARTICIPANTS AND PRODUCTS

4.5.2.4.  KEY CONCLUSIONS

4.5.2.5.  SUBSEGMENT

4.5.2.5.1.        CARDIOVASCULAR DISEASES

4.5.2.5.2.        CARDIOVASCULAR DISEASES

4.5.2.5.3.        CHRONIC RESPIRATORY DISEASES (CRD)

4.5.2.5.4.        DIABETES

4.5.2.5.5.        MEDICATION ADHERENCE

4.5.2.5.6.        MUSCULOSKELETAL DISORDERS

4.5.2.5.7.        SMOKING CESSATION

4.5.2.5.8.        OTHER APPLICATIONS

4.6. GLOBAL DIGITAL THERAPEUTICS MARKET BY  SALES CHANNEL MARKET

4.7. MARKET DEFINITION AND SCOPE

4.8. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.9. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.10.                   OPPORTUNITY MATRIX

4.11.                  MARKET SEGMENTATION

4.11.1.  GLOBAL BUSINESS TO BUSINESS  SALES CHANNEL MARKET

4.11.1.1.                      ADOPTION SCENARIO & MARKET DETERMINANTS

4.11.1.2.                      MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.11.1.3.                      MARKET PARTICIPANTS AND PRODUCTS

4.11.1.4.                      KEY CONCLUSIONS

4.11.2.  GLOBAL EMPLOYERS  SALES MARKET

4.11.2.1.                      ADOPTION SCENARIO & MARKET DETERMINANTS

4.11.2.2.                      MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.11.2.3.                      MARKET PARTICIPANTS AND PRODUCTS

4.11.2.4.                      KEY CONCLUSIONS

4.11.3.  GLOBAL PAYERS MARKET

4.11.3.1.                      ADOPTION SCENARIO & MARKET DETERMINANTS

4.11.3.2.                      MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.11.3.3.                      MARKET PARTICIPANTS AND PRODUCTS

4.11.3.4.                      KEY CONCLUSIONS

4.11.3.5.                      SUBSEGMENT

4.11.3.5.1.    PHARMACEUTICALS COMPANIES

4.11.3.5.2.    PROVIDERS

 

4.11.3.5.3.    OTHERS BUYERS

4.11.4.  GLOBAL LOBAL BUSINESS TO CONSUMER SALES CHANNEL MARKET

4.11.4.1.                      ADOPTION SCENARIO & MARKET DETERMINANTS

4.11.4.2.                      MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.11.4.3.                      MARKET PARTICIPANTS AND PRODUCTS

4.11.4.4.                      KEY CONCLUSIONS

4.11.4.5.                      SUBSEGMENT

4.11.4.5.1.    AREGIVERS MARKET

5.       COMPETITIVE LANDSCAPE

5.1. KEY STRATEGIES

5.1.1.        LIST OF MERGERS AND ACQUISITION

5.1.2.        LIST OF JOINT VENTURES

5.1.3.        LIST OF PRODUCT LAUNCHES

5.1.4.        LIST OF PARTNERSHIPS

6.       GEOGRAPHIC ANALYSIS

6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.3. OPPORTUNITY MATRIX

6.4.                      GLOBAL DIGITAL THERAPEUTIC MARKET BY REGION 2015-2024  

6.4.1.      NORTH AMERICA

6.4.1.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

6.4.1.2.  TOP COUNTRY ANALYSIS

6.4.1.2.1.      U.S.

6.4.1.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.4.1.2.1.2.   MARKET PARTICIPANTS AND PRODUCTS

6.4.1.2.1.3.   KEY CONCLUSIONS

6.4.1.2.2.      CANADA

6.4.1.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.4.1.2.2.2.   MARKET PARTICIPANTS AND PRODUCTS

6.4.1.2.2.3.   KEY CONCLUSIONS

6.4.2.      EUROPE

6.4.2.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

6.4.2.2.  TOP COUNTRY ANALYSIS

6.4.2.2.1.      UK

6.4.2.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.4.2.2.1.2.   MARKET PARTICIPANTS AND PRODUCTS

6.4.2.2.1.3.   KEY CONCLUSIONS

6.4.2.2.2.      FRANCE

6.4.2.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.4.2.2.2.2.   MARKET PARTICIPANTS AND PRODUCTS

6.4.2.2.2.3.   KEY CONCLUSIONS

6.4.2.2.3.      GERMANY

6.4.2.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.4.2.2.3.2.   MARKET PARTICIPANTS AND PRODUCTS

6.4.2.2.3.3.   KEY CONCLUSIONS

6.4.2.2.4.      SPAIN

6.4.2.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.4.2.2.4.2.   MARKET PARTICIPANTS AND PRODUCTS

6.4.2.2.4.3.   KEY CONCLUSIONS

6.4.2.2.5.      REST OF EUROPE

6.4.2.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.4.2.2.5.2.   KEY  PLAYERS & KEY PRODUCTS

6.4.2.2.5.3.   KEY CONCLUSIONS

6.4.3.      ASIA PACIFIC

6.4.3.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

6.4.3.2.  TOP COUNTRY ANALYSIS

6.4.3.2.1.      CHINA

6.4.3.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.4.3.2.1.2.   MARKET PARTICIPANTS AND PRODUCTS

6.4.3.2.1.3.   KEY CONCLUSIONS

6.4.3.2.2.      INDIA

6.4.3.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.4.3.2.2.2.   MARKET PARTICIPANTS AND PRODUCTS

6.4.3.2.2.3.   KEY CONCLUSIONS

6.4.3.2.3.      JAPAN

6.4.3.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.4.3.2.3.2.   MARKET PARTICIPANTS AND PRODUCTS

6.4.3.2.3.3.   KEY CONCLUSIONS

6.4.3.2.4.      AUSTRALIA

6.4.3.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.4.3.2.4.2.   KEY  PLAYERS & KEY PRODUCTS

6.4.3.2.4.3.   KEY CONCLUSIONS

6.4.3.2.5.      REST OF ASIA PACIFIC

6.4.3.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.4.3.2.5.2.   KEY  PLAYERS & KEY PRODUCTS

6.4.3.2.5.3.   KEY CONCLUSIONS

6.4.4.      ROW

6.4.4.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

6.4.4.2.  TOP COUNTRY ANALYSIS

6.4.4.2.1.      LATIN AMERICA

6.4.4.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.4.4.2.1.2.   MARKET PARTICIPANTS AND PRODUCTS

6.4.4.2.1.3.   KEY CONCLUSIONS

6.4.4.2.2.      MIDDLE EAST & AFRICA

6.4.4.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.4.4.2.2.2.   MARKET PARTICIPANTS AND PRODUCTS

6.4.4.2.2.3.   KEY CONCLUSIONS

7.       COMPANY PROFILES

7.1. A  ADHERETECH  (US)

7.1.1.        OVERVIEW

7.1.2.        PRODUCT PORTFOLIO

7.1.3.        STRATEGIC INITIATIVES

7.1.4.        SCOT ANALYSIS

7.1.5.        STRATEGIC ANALYSIS

7.2. BOSTON SCIENTIFIC (US)

7.2.1.        OVERVIEW

7.2.2.        PRODUCT PORTFOLIO

7.2.3.        STRATEGIC INITIATIVES

7.2.4.        SCOT ANALYSIS

7.2.5.        STRATEGIC ANALYSIS

7.3. CANARY HEALTH INC (US)

7.3.1.        OVERVIEW

7.3.2.        PRODUCT PORTFOLIO

7.3.3.        STRATEGIC INITIATIVES

7.3.4.        SCOT ANALYSIS

7.3.5.        STRATEGIC ANALYSIS

7.4. DOXIMITY (US)

7.4.1.        OVERVIEW

7.4.2.        PRODUCT PORTFOLIO

7.4.3.        STRATEGIC INITIATIVES

7.4.4.        SCOT ANALYSIS

7.4.5.        STRATEGIC ANALYSIS

7.5. EVOLENT HEALTH (US)

7.5.1.        OVERVIEW

7.5.2.        PRODUCT PORTFOLIO

7.5.3.        STRATEGIC INITIATIVES

7.5.4.        SCOT ANALYSIS

7.5.5.        STRATEGIC ANALYSIS

7.6. GE HEALTHCARE (US)

7.6.1.        OVERVIEW

7.6.2.        PRODUCT PORTFOLIO

7.6.3.        STRATEGIC INITIATIVES

7.6.4.        SCOT ANALYSIS

7.6.5.        STRATEGIC ANALYSIS

7.7. LIVONGO HEALTH (US)

7.7.1.        OVERVIEW

7.7.2.        PRODUCT PORTFOLIO

7.7.3.        STRATEGIC INITIATIVES

7.7.4.        SCOT ANALYSIS

7.7.5.        STRATEGIC ANALYSIS

7.8. MANGO HEALTH INC (US)

7.8.1.        OVERVIEW

7.8.2.        PRODUCT PORTFOLIO

7.8.3.        STRATEGIC INITIATIVES

7.8.4.        SCOT ANALYSIS

7.8.5.        STRATEGIC ANALYSIS

7.9. MEDTRONIC (US)

7.9.1.        OVERVIEW

7.9.2.        PRODUCT PORTFOLIO

7.9.3.        STRATEGIC INITIATIVES

7.9.4.        SCOT ANALYSIS

7.9.5.        STRATEGIC ANALYSIS

7.10.                  OMADA HEALTH, INC.(US)

7.10.1.   OVERVIEW

7.10.2.   PRODUCT PORTFOLIO

7.10.3.   STRATEGIC INITIATIVES

7.10.4.   SCOT ANALYSIS

7.10.5.   STRATEGIC ANALYSIS

7.11.                  PROPELLER HEALTH (US)

7.11.1.   OVERVIEW

7.11.2.   PRODUCT PORTFOLIO

7.11.3.   STRATEGIC INITIATIVES

7.11.4.   SCOT ANALYSIS

7.11.5.   STRATEGIC ANALYSIS

7.12.                  PROTEUS DIGITAL HEALTH, INC (US)

7.12.1.   OVERVIEW

7.12.2.   PRODUCT PORTFOLIO

7.12.3.   STRATEGIC INITIATIVES

7.12.4.   SCOT ANALYSIS

7.12.5.   STRATEGIC ANALYSIS

7.13.                  SIEMENS (GERMANY)

7.13.1.   OVERVIEW

7.13.2.   PRODUCT PORTFOLIO

7.13.3.   STRATEGIC INITIATIVES

7.13.4.   SCOT ANALYSIS

7.13.5.   STRATEGIC ANALYSIS

7.14.                  WELLDOC, INC (US)

7.14.1.   OVERVIEW 

7.14.2.   PRODUCT PORTFOLIO

7.14.3.   STRATEGIC INITIATIVES

7.14.4.   SCOT ANALYSIS

7.14.5.   STRATEGIC ANALYSIS

7.15.                  ZEST HEALTH (US)

7.15.1.   OVERVIEW

7.15.2.   PRODUCT PORTFOLIO

7.15.3.   STRATEGIC INITIATIVES

7.15.4.   SCOT ANALYSIS

7.15.5.   STRATEGIC ANALYSIS

LIST OF TABLES

1.       GLOBAL DIGITAL THERAPEUTIC MARKET BY APPLICATION 2015-2024 ($ MILLION)

2.       GLOBAL PREVENTIVE APPLICATIONS APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL DIGITAL THERAPEUTIC MARKET BY OBESITY  GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL DIGITAL THERAPEUTIC MARKKET  BY CARDIOVASCULAR DISEASES MARKET MARKET BY PREDIABETES GEOGRAPHY 2015-2024 ($ MILLION)

5.       GLOBAL DIGITAL THERAPEUTIC MARKKET  BY CENTRAL NERVOUS SYSTEM (CNS) DISORDERS 2015-2024 ($ MILLION)

6.       GLOBAL DIGITAL THERAPEUTIC MARKKET  BY CHRONIC RESPIRATORY DISEASES (CRD) MARKET  2015-2024 ($ MILLION)

7.       GLOBAL DIGITAL THERAPEUTIC MARKKET  BY DIABETES MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

8.       GLOBAL DIGITAL THERAPEUTIC MARKKET  BY MEDICATION ADHERENCE  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       GLOBAL DIGITAL THERAPEUTIC MARKKET BY   MUSCULOSKELETAL DISORDERS  BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   GLOBAL DIGITAL THERAPEUTIC MARKKET BY OTHER APPLICATIONS MARKET BY 2015-2024 ($ MILLION)

11.   GLOBAL COMPLIANCE MANAGEMENT/ KYC MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

12.   GLOBAL OTHERS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

13.   GLOBAL DIGITAL THERAPEUTIC MARKET BY  SALES CHANNEL  2015-2024 ($ MILLION)

14.   GLOBAL BUSINESS TO BUSINESS 2015-2024 ($ MILLION)

15.   GLOBAL EMPLOYERS SALES CHANNEL BY GEOGRAPHY 2015-2024 ($ MILLION)

16.   GLOBAL PAYERS SALES CHANNEL BY GEOGRAPHY 2015-2024 ($ MILLION)

17.   DIGITAL THERAPEUTIC MARKET BY  PHARMACEUTICALS COMPANIES BY 2015-2024 ($ MILLION)

18.   DIGITAL THERAPEUTIC MARKET BY PROVIDERS MARKET BY 2015-2024 ($ MILLION)

19.   GLOBAL DIGITAL THERAPEUTIC MARKET BY OTHERS BUYERS’ BY 2015-2024 ($ MILLION)

20.   GLOBAL BUSINESS TO CONSUMER MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

21.   GLOBAL  CAREGIVERS SALES CHANNEL  MARKET 2014-2023 ($ MILLION) 

22.   NORTH AMERICA DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

23.   EUROPE DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

24.   ASIA PACIFIC DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

25.   REST OF THE WORLD DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

26.   NORTH AMERICA DIGITAL THERAPEUTIC MARKET BY APPLICATION 2015-2024 ($ MILLION)

27.   EUROPE DIGITAL THERAPEUTIC MARKET BY APPLICATION 2015-2024 ($ MILLION)

28.   ASIA PACIFIC DIGITAL THERAPEUTIC MARKET BY APPLICATION 2015-2024 ($ MILLION)

29.   REST OF THE WORLD FINTECH BLOCKCHAINMARKET BY APPLICATION 2015-2024 ($ MILLION)

30.   NORTH AMERICA DIGITAL THERAPEUTIC  MARKET BY  SALES CHANNEL 2015-2024 ($ MILLION)

31.   EUROPE DIGITAL THERAPEUTIC MARKET BY  SALES CHANNEL 2015-2024 ($ MILLION)

32.   ASIA PACIFIC DIGITAL THERAPEUTIC  MARKET BY  SALES CHANNEL 2015-2024 ($ MILLION)

33.   REST OF THE WORLD DIGITAL THERAPEUTIC  MARKET BY  SALES CHANNEL  2015-2024 ($ MILLION)

34.   UNITED STATES DIGITAL THERAPEUTIC  MARKET BY APPLICATION 2015-2024 ($ MILLION)

35.   UNITED STATES DIGITAL THERAPEUTIC  MARKET BY  SALES CHANNEL 2015-2024 ($ MILLION)

36.   UNITED STATES DIGITAL THERAPEUTIC  MARKET BY VERTICAL 2015-2024 ($ MILLION)

37.   CANADA DIGITAL THERAPEUTIC  MARKET BY APPLICATION 2015-2024 ($ MILLION)

38.   CANADA DIGITAL THERAPEUTIC  MARKET BY  SALES CHANNEL 2015-2024 ($ MILLION)

39.   UK DIGITAL THERAPEUTIC  MARKET BY APPLICATION 2015-2024 ($ MILLION)

40.   UK DIGITAL THERAPEUTIC  MARKET BY  SALES CHANNEL 2015-2024 ($ MILLION)

41.   FRANCE DIGITAL THERAPEUTIC  MARKET BY APPLICATION 2015-2024 ($ MILLION)

42.   FRANCE DIGITAL THERAPEUTIC  MARKET BY  SALES CHANNEL 2015-2024 ($ MILLION)

43.   GERMANY DIGITAL THERAPEUTIC  MARKET BY APPLICATION 2015-2024 ($ MILLION)

44.   GERMANY DIGITAL THERAPEUTIC  MARKET BY  SALES CHANNEL 2015-2024 ($ MILLION)

45.   SPAIN DIGITAL THERAPEUTIC  MARKET BY APPLICATION 2015-2024 ($ MILLION)

46.   SPAIN DIGITAL THERAPEUTIC  MARKET BY  SALES CHANNEL 2015-2024 ($ MILLION)

47.   ROE DIGITAL THERAPEUTIC  MARKET BY APPLICATION 2015-2024 ($ MILLION)

48.   UNROE TED STATES DIGITAL THERAPEUTIC  MARKET BY  SALES CHANNEL 2015-2024 ($ MILLION)

49.   CHINA DIGITAL THERAPEUTIC  MARKET BY APPLICATION 2015-2024 ($ MILLION)

50.   CHINA DIGITAL THERAPEUTIC  MARKET BY  SALES CHANNEL 2015-2024 ($ MILLION)

LIST OF FIGURES

1.       GLOBAL PREVENTIVE APPLICATIONS APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

2.       GLOBAL DIGITAL THERAPEUTIC MARKKET  BY CARDIOVASCULAR DISEASES MARKET BY PREDIABETES GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL COMPLIANCE MANAGEMENT/ KYC MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL OTHERS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

5.       GLOBAL DIGITAL THERAPEUTIC MARKET BY  SALES CHANNEL  2015-2024 ($ MILLION)

6.       GLOBAL BUSINESS TO BUSINESS 2015-2024 ($ MILLION)

7.       GLOBAL EMPLOYERS SALES CHANNEL BY GEOGRAPHY 2015-2024 ($ MILLION)

8.       GLOBAL PAYERS SALES CHANNEL BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       DIGITAL THERAPEUTIC MARKET BY  PHARMACEUTICALS COMPANIES BY 2015-2024 ($ MILLION)

10.   GLOBAL BUSINESS TO CONSUMER MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

11.   GLOBAL  CAREGIVERS SALES CHANNEL  MARKET 2014-2023 ($ MILLION) 

12.   UNITED STATES (U.S.) DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

13.   CANADA DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

14.   UNITED KINGDOM (UK) DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

15.   FRANCE DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

16.   GERMANY DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

17.   SPAIN DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

18.   ROE DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

19.   CHINA DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

20.   INDIA DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

21.   JAPAN DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

22.   AUSTRALIA DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

23.   ROAPAC DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

24.   LATIN AMERICA DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION)

25.   MENA DIGITAL THERAPEUTIC MARKET 2015-2024 ($ MILLION) 

 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.